Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
Fiche publication
Date publication
juillet 2016
Journal
Geriatrics & gerontology international
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Mione G, Ducrocq X, Thilly N, Lacour JC, Vespignani H, Richard S
Lien Pubmed
Résumé
Practitioners are faced with a substantial challenge when considering recombinant tissue plasminogen activator (rt-PA) therapy for older patients with ischemic stroke. Patients aged over 80 years suffer from the most severe cerebral infarcts. The benefit of rt-PA treatment compared with single standard care only in stroke units remains to be clearly assessed.
Mots clés
Administration, Intravenous, Age Factors, Aged, 80 and over, Brain Ischemia, drug therapy, Female, Fibrinolytic Agents, therapeutic use, Humans, Male, Retrospective Studies, Stroke, drug therapy, Tissue Plasminogen Activator, therapeutic use, Treatment Outcome
Référence
Geriatr Gerontol Int. 2016 Jul;16(7):843-9